EP3641833 - METHODS AND COMPOSITIONS FOR CONTROLLING CARDIAC FIBROSIS AND REMODELING [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 19.11.2020 Database last updated on 05.07.2024 | |
Former | Request for examination was made Status updated on 27.03.2020 | ||
Former | The international publication has been made Status updated on 31.12.2018 | ||
Former | unknown Status updated on 23.06.2018 | Most recent event Tooltip | 24.06.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Université de Lausanne Rue de Bugnon 21 1011 Lausanne / CH | [2020/18] | Inventor(s) | 01 /
OUNZAIN, Samir Avenue de Beaumont 56 1010 Lausanne / CH | 02 /
PEDRAZZINI, Thierry Chemin des Grisons 1 1052 Le Mont-sur-Lausanne / CH | [2020/23] |
Former [2020/18] | 01 /
OUNZAIN, Samir Chemin Isabelle-de-Montolieu 90 1010 Lausanne / CH | ||
02 /
PEDRAZZINI, Thierry Chemin des Grisons 1 1052 Le Mont-sur-Lausanne / CH | Representative(s) | KATZAROV S.A. Geneva Business Center 12 Avenue des Morgines 1213 Petit-Lancy / CH | [N/P] |
Former [2020/18] | KATZAROV S.A. European Patent Attorneys 12, Avenue des Morgines 1213 Petit-Lancy / CH | Application number, filing date | 18730384.7 | 19.06.2018 | [2020/18] | WO2018EP66206 | Priority number, date | EP20170176725 | 19.06.2017 Original published format: EP 17176725 | [2020/18] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018234283 | Date: | 27.12.2018 | Language: | EN | [2018/52] | Type: | A1 Application with search report | No.: | EP3641833 | Date: | 29.04.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.12.2018 takes the place of the publication of the European patent application. | [2020/18] | Search report(s) | International search report - published on: | EP | 27.12.2018 | Classification | IPC: | A61K48/00, C12N15/113, A61K31/7088, C12N15/63 | [2020/18] | CPC: |
C12N15/113 (EP,US);
A61K31/7088 (EP,US);
A61P9/00 (EP);
C12N9/22 (US);
C12N2310/11 (EP,US);
C12N2310/141 (US);
C12N2310/20 (US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/18] | Extension states | BA | 16.01.2020 | ME | 16.01.2020 | Validation states | KH | 16.01.2020 | MA | 16.01.2020 | MD | 16.01.2020 | TN | 16.01.2020 | Title | German: | VERFAHREN UND ZUSAMMENSETZUNGEN ZUR KONTROLLE VON HERZFIBROSE UND REMODELLIERUNG | [2020/18] | English: | METHODS AND COMPOSITIONS FOR CONTROLLING CARDIAC FIBROSIS AND REMODELING | [2020/18] | French: | MÉTHODES ET COMPOSITIONS POUR RÉGULER LA FIBROSE ET LE REMODELAGE CARDIAQUE | [2020/18] | Entry into regional phase | 16.01.2020 | National basic fee paid | 16.01.2020 | Designation fee(s) paid | 16.01.2020 | Examination fee paid | Examination procedure | 16.01.2020 | Examination requested [2020/18] | 16.01.2020 | Date on which the examining division has become responsible | 07.07.2020 | Amendment by applicant (claims and/or description) | 18.11.2020 | Despatch of a communication from the examining division (Time limit: M04) | 12.03.2021 | Reply to a communication from the examining division | 22.02.2022 | Despatch of a communication from the examining division (Time limit: M06) | 22.08.2022 | Reply to a communication from the examining division | 26.06.2023 | Despatch of a communication from the examining division (Time limit: M06) | 08.11.2023 | Reply to a communication from the examining division | Fees paid | Renewal fee | 16.01.2020 | Renewal fee patent year 03 | 25.06.2021 | Renewal fee patent year 04 | 29.06.2022 | Renewal fee patent year 05 | 20.06.2023 | Renewal fee patent year 06 | 24.06.2024 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI]WO2015092020 (UNIVERSITÉ DE LAUSANNE [CH]); | [X]WO2015162161 (HANNOVER MED HOCHSCHULE [DE]); |